Piyasa kapalı· · NOK · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Reference is made to the stock exchange announcement made by SalMar ASA ("SalMar" or the "Company") on 25 August 2026 of the launch of SalMar’s share buyback program to purchase up to 100,000 of the Company's shares for a total amount of up to NOK 65 million during the period from 25 August 2026, until no later than 30 September 2026, pursuant to an agreement with DNB Carnegie, a part of DNB Bank ASA. SalMar has now completed the share buyback program. A total of 100,000 shares, which equals 0.0
For the complete transcript of the earnings call, please refer to the full earnings call transcript. Record strong biological performance with mortality 40% lower, growth 33% higher, and superior share 9 percentage points higher than the 10-year average. Acquisition of Msval expected to generate annual operational cost synergies of approximately NOK300 million.
Strong operational and biological performance in Norway resulted in a record-high harvest volume for a second quarter and a significant improvement in earnings compared with the same period last year. Higher volumes, improved fish quality, and lower costs throughout the value chain contributed positively, while an unfavourable harvest profile, with the majority of volumes harvested in June, negatively impacted price achievement during the period. Operational EBIT for the Group amounted to NOK 1,
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.